TrialClinical cardiology2017

Rationale and design of a randomized trial of apixaban vs warfarin to evaluate atherosclerotic calcification and vulnerable plaque progression.

Kazuhiro Osawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.